| 1 |
32172203 | Aspirin enhances regulatory functional activities of monocytes and downregulates CD16 and CD40 expression in myocardial infarction autoinflammatory disease. | 2020 Jun |
5 |
| 2 |
27412561 | miR-145 mediated the role of aspirin in resisting VSMCs proliferation and anti-inflammation through CD40. | 2016 Jul 13 |
3 |
| 3 |
25648873 | Reproducibility over time and effect of low-dose aspirin on soluble P-selectin and soluble CD40 ligand. | 2015 Jul |
1 |
| 4 |
26237513 | Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization. | 2015 |
1 |
| 5 |
22159558 | SNX3-dependent regulation of epidermal growth factor receptor (EGFR) trafficking and degradation by aspirin in epidermoid carcinoma (A-431) cells. | 2012 May |
1 |
| 6 |
23057161 | Drug modification of LPS-stimulated human monocyte-derived dendritic cells. | 2012 |
1 |
| 7 |
19031027 | Aspirin and the induction of tolerance by dendritic cells. | 2009 |
1 |
| 8 |
19298588 | Soluble CD40 ligand and endothelial dysfunction in aspirin-treated polycythaemia vera patients. | 2009 May |
1 |
| 9 |
17615799 | Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease. | 2007 May |
2 |
| 10 |
17219690 | Aspirin modified dendritic cells are potent inducers of allo-specific regulatory T-cells. | 2006 Dec 20 |
1 |
| 11 |
12615789 | Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation. | 2003 Mar 4 |
1 |